Andrew B. Song, Gerald A. Soff. Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia. // American Journal of Hematology. – 2026. – DOI: 10.1002/ajh.70510. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ajh.70510?af=R
Andrew B. Song & Gerald A. Soff (2026). Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia. American Journal of Hematology. https://doi.org/10.1002/ajh.70510
Andrew B. Song and Gerald A. Soff. “Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia.” American Journal of Hematology, 2026. doi:10.1002/ajh.70510.
@article{Song2026,
title = {Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia},
author = {Song, Andrew B. and Soff, Gerald A.},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70510},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ajh.70510?af=R}
}